cervical pre-cancer
Predica Diagnostics Developing Targeted Sequencing Test for Cervical Cancer Diagnosis, Screening
Premium
The test is based on targeted circular probe-based RNA next-generation sequencing (ciRNAseq), which enables a high degree of multiplexing and mutational analysis.
FDA-Cleared Digital Cytology System Delivers Next-Gen Technology for Pap Testing, Hologic Says
Premium
The firm began selling the Genius Digital Diagnostics System in Europe about two years ago and will soon make the platform available in the US on the heels of its FDA clearance.
Becton Dickinson, TechCyte Ink Strategic Collaboration for Automated Cervical Cancer Cytology
The BD and TechCyte solution will be commercially available in Europe in the first half of 2024, and in the US subject to FDA approval.
Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy
The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia.
Hologic Obtains CE Mark for AI-Based Cervical Cancer Screening Platform
Hologic designed its scalable AI-based cytology platform to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.